"Abortion" from_date:2012

Evaluation of taking mifepristone at home during a medical abortion ConsentDetailsAboutThis website uses cookiesWe use cookies to facilitate your visit, provide social media features and analyze our traffic to continuously improve the website. Read more about cookiesCustomizeAllow all cookiesPowered by Cookiebot by UsercentricsHoppa till textinnehålletMenuSearchEvaluation of taking mifepristone at home during a medical abortion Reading time less than 1 minute Published: May 9, 2023 Publication type: SBU Assessment Share:  A manuscript is in preparation for submission to a peer-reviewed journal. Contact SBUPublished:May 9, 2023Report no:363Registration no:SBU 2022/30ISBN:978-91-987553-9-8https://www.sbu.se/363eTo top Page published May 9, 2023 SBU – Swedish Agency for Health Technology

Abortion - Accessing abortion services Cookies on the NICE website and servicesCookies are files saved on your phone, tablet or computer when you visit a website.We use cookies to store information about how you use the NICE website and services, such as the pages you visit.For more information, view our cookie statement.(Opens in a new window)Accept all cookiesReject cookiesEssential on these adverts.Show vendors within this categoryMarketing and advertising cookiesOnOffSkip to contentAccessibility helpSearch CKS…Search CKS…Skip to contentMenuNICECKSHealth topics A to ZAbortionBackground informationAccessing abortion servicesAbortion:How can a person access abortion services?last revised in March 2024SummaryHave I got the right topic?How up-to-date is this topic?Goals and outcome

Abortion - UK abortion laws Cookies on the NICE website and servicesCookies are files saved on your phone, tablet or computer when you visit a website.We use cookies to store information about how you use the NICE website and services, such as the pages you visit.For more information, view our cookie statement.(Opens in a new window)Accept all cookiesReject cookiesEssential cookiesThese cookies on these adverts.Show vendors within this categoryMarketing and advertising cookiesOnOffSkip to contentAccessibility helpSearch CKS…Search CKS…Skip to contentMenuNICECKSHealth topics A to ZAbortionBackground informationUK abortion lawsAbortion:What are the UK abortion laws?last revised in March 2024SummaryHave I got the right topic?How up-to-date is this topic?Goals and outcome measuresBackground

Abortion - Methods of abortion Cookies on the NICE website and servicesCookies are files saved on your phone, tablet or computer when you visit a website.We use cookies to store information about how you use the NICE website and services, such as the pages you visit.For more information, view our cookie statement.(Opens in a new window)Accept all cookiesReject cookiesEssential cookiesThese on these adverts.Show vendors within this categoryMarketing and advertising cookiesOnOffSkip to contentAccessibility helpSearch CKS…Search CKS…Skip to contentMenuNICECKSHealth topics A to ZAbortionBackground informationMethods of abortionAbortion:What methods of abortion are available?last revised in March 2024SummaryHave I got the right topic?How up-to-date is this topic?Goals and outcome measuresBackground

Termination of Pregnancy and Abortion Care CLINICAL PROFESSIONAL RESOURCETermination of Pregnancy and Abortion CareClinical guidance TERMINATION OF PREGNANCY AND ABORTION CAREAcknowledgementsThe Royal College of Nursing (RCN) would like to thank the project team for the development of this publication: Michael Nevill, (Project Chair) RCN Women’s Health Forum Committee memberRuth Bailey, Chair .............................................................................................................................................15Whose decision is it? .........................................................................................................................................15Pre-abortion assessment ...............................................................................................................................16 Pregnancy termination methods

Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of Gestation Obstetrics & Gynecology You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page. * ACOG.org * ACOG Clinical * Green Journal * O&G Open * For Patients * Store * ACOG.org * ACOG Clinical * Green Journal * O&G Open * For Parents sent to your colleague. Some error has occurred while processing your request. Please try after some time. Export to End Note Procite Reference Manager Save my selection ACOG PublicationsACOG Clinical Practice Update: Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of GestationAuthor Information The American College of Obstetricians and Gynecologists

Increasing Access to Abortion Increasing Access to Abortion | ACOG Skip to main content * Clinical Guidance * Practice Bulletin * Clinical Practice Guideline * Committee Statement * Committee Opinion * Clinical Consensus * Practice Advisory * Obstetric Care Consensus * ACOG Endorsed * Technology Assessment * Task Force Report * Clinical Practice Update * Journals & Publications * Clinical Updates * Pregnancy Complications * Reproductive Physiological Phenomena * Vaccines Search * Clinical Guidance * Committee Statement * Increasing Access to Abortion Increasing Access to Abortion * Committee Statement CS * Number 16 * February 2025 * Jump to Jump to Close * Summary of Recommendations and Conclusions * Background * Recommendations and Conclusions * Conclusion * Conflict of Interest Statement * Search

Abortion care NHS England » Abortion care Skip to main content Cookies on the NHS England websiteWe’ve put some small files called cookies on your device to make our site work. We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site. Let us know if this is OK. We’ll use a cookie to save your choice. You canread more about our cookies before you choose. Change my preferences I'm OK with analytics cookies * Home * News * Publications * Statistics * Blogs * Events * Contact us Search Search Menu * About us * Our work * Commissioning * Get involved Abortion careDocument first published: 17 March 2025 Page updated: 17 March 2025 Topic: Commissioning, Integrated care Publication type

Review of Certain Matters under the Contraception, Sterilisation, and Abortion Act 1977 Released 2025 health.govt.nz Released 2025 health.govt.nz Review of Certain Matters under the Contraception, Sterilisation, and Abortion Act 1977 Presented to the House of Representatives pursuant to section 22 of the Contraception, Sterilisation, and Abortion Act 1977 Citation: Ministry of Health. 2025 . Review of Certain Matters under the Contraception, Sterilisation, and Abortion Act 1977. Wellington: Ministry of Health. Published in April 2025 by the Ministry of Health PO Box 5013, Wellington 6140, New Zealand ISBN 978-1-991324-25-2 (print) ISBN 978-1-991324-26-9 (online) HP 9118 This document is available at health.govt.nz This work is licensed under the Creative Commons Attribution 4.0

Management of undesired pregnancy of unknown location and abortion at less than 42 days of gestation Journal Pre-proofSociety of Family Planning ClinicalRecommendation: Management of undesiredpregnancy of unknown location and abortion at lessthan 42 days of gestationSiripanth Nippita, Catherine Cansino, Alisa B.Goldberg, Neena Qasba, Katharine White, VinitaGoyal, Angeline Ti, Christy BoraasPII:S0010-7824(25)00056-3DOI: appear in:ContraceptionRevised date:27 February 2025Accepted date:10Please cite this article as: Siripanth Nippita, Catherine Cansino, Alisa B.Goldberg, Neena Qasba, Katharine White, Vinita Goyal, Angeline Ti and ChristyBoraas, Society of Family Planning Clinical Recommendation: Management ofundesired pregnancy of unknown location and abortion at less than 42 days ofgestation

Improving abortion care Skip to main contentCookies on the NHS England websiteWe’ve put some small files called cookies on your device to make our site work.We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.Let us know if this is OK. We’ll use a cookie to save your choice . You can read more about our cookies before you choose. Change my preferences I'm OK with analytics cookiesHome News Publications Statistics Blogs Events Contact usSearch SearchAbout us Our work Commissioning Get involved CoronavirusImproving abortion careDocument first published:12 March 2024Page updated:10 April 2024Topic:Patient carePublication type:Guidance, LetterThis letter sets out the NHS

Abortion - Management Cookies on the NICE website and servicesCookies are files saved on your phone, tablet or computer when you visit a website.We use cookies to store information about how you use the NICE website and services, such as the pages you visit.For more information, view our cookie statement.(Opens in a new window)Accept all cookiesReject cookiesEssential cookiesThese cookies enable measuresBackground informationManagementScenario: ManagementSupporting evidenceHow this topic was developedReferencesOn this pageManagementScenario: ManagementFrom age 16 years onwards (Female).How should I manage a person considering an abortion?All aspects of abortion care should be delivered in a respectful, empathetic, and sensitive manner that is person-centred and recognizes the pregnant person

Abortion - Complications and risks Cookies on the NICE website and servicesCookies are files saved on your phone, tablet or computer when you visit a website.We use cookies to store information about how you use the NICE website and services, such as the pages you visit.For more information, view our cookie statement.(Opens in a new window)Accept all cookiesReject cookiesEssential cookiesThese on these adverts.Show vendors within this categoryMarketing and advertising cookiesOnOffSkip to contentAccessibility helpSearch CKS…Search CKS…Skip to contentMenuNICECKSHealth topics A to ZAbortionBackground informationComplications and risksAbortion:What are the complications and risks of an abortion?last revised in March 2024SummaryHave I got the right topic?How up-to-date is this topic?Goals and outcome

Abortion - Prevalence Cookies on the NICE website and servicesCookies are files saved on your phone, tablet or computer when you visit a website.We use cookies to store information about how you use the NICE website and services, such as the pages you visit.For more information, view our cookie statement.(Opens in a new window)Accept all cookiesReject cookiesEssential cookiesThese cookies enable on these adverts.Show vendors within this categoryMarketing and advertising cookiesOnOffSkip to contentAccessibility helpSearch CKS…Search CKS…Skip to contentMenuNICECKSHealth topics A to ZAbortionBackground informationPrevalenceAbortion:How common is abortion?last revised in March 2024SummaryHave I got the right topic?How up-to-date is this topic?Goals and outcome measuresBackground informationDefinitionUK abortion

Abortion - Definition Cookies on the NICE website and servicesCookies are files saved on your phone, tablet or computer when you visit a website.We use cookies to store information about how you use the NICE website and services, such as the pages you visit.For more information, view our cookie statement.(Opens in a new window)Accept all cookiesReject cookiesEssential cookiesThese cookies enable on these adverts.Show vendors within this categoryMarketing and advertising cookiesOnOffSkip to contentAccessibility helpSearch CKS…Search CKS…Skip to contentMenuNICECKSHealth topics A to ZAbortionBackground informationDefinitionAbortion:What is an abortion?last revised in March 2024SummaryHave I got the right topic?How up-to-date is this topic?Goals and outcome measuresBackground informationDefinitionUK abortion

Induction of fetal asystole before abortion Contents lists available at ScienceDirectContraceptionjournal homepage: www.elsevier.com/locate/contraceptionSociety of Family Planning Clinical Recommendation: Induction of fetal asystole before abortion Jointly developed with the Society for Maternal-Fetal Medicine☆,☆☆Justin Diedrich a,⁎, Caroline N. Goldfarb b, Shandhini Raidoo c, Eleanor Drey d of California, San Francisco, San Francisco, CA 94110, United States e Dupont Clinic, Washington, DC, United States f Johns Hopkins School of Public Health, Baltimore, MD, United States article infoArticle history: Received 16 January 2024 Received in revised form 16 July 2024 Accepted 22 July 2024Keywords: Abortion Digoxin Fetal asystole Feticide Lidocaine Potassium chlorideabstractThis document serves

Self-Managed Abortion Self-Managed Abortion | ACOG Skip to main content * Clinical Guidance * Practice Bulletin * Clinical Practice Guideline * Committee Statement * Committee Opinion * Clinical Consensus * Practice Advisory * Obstetric Care Consensus * ACOG Endorsed * Technology Assessment * Task Force Report * Clinical Practice Update * Journals & Publications * Clinical Updates * Obstetrics Complications * Reproductive Physiological Phenomena * Vaccines Search * Clinical Guidance * Committee Statement * Self-Managed Abortion Self-Managed Abortion * Committee Statement CS * Number 13 * December 2024 * Jump to Jump to Close * Recommendations and Conclusions * Background * Recommendations and Conclusions * Conclusion * Conflict of Interest Statement * Search page Search Page Close * Resources

Clinical Guideline for Abortion Care Clinical Guideline for Abortion Care - RANZCOG Clinical Guideline for Abortion Care - RANZCOG Donate : /donate Find an O&G : Member sign in : Search : /search * Training * CPD * Membership * Women’s health * Our College * Contact us * Search : /search Donate : /donate Find an O&G : Member sign in : Search : /search * Training * Train with us * Current trainees Guideline for Abortion Care SummaryRANZCOG has published the first binational evidence-based clinical practice guideline on abortion care for Australia and Aotearoa New Zealand. The purpose of this guideline is to provide evidence-based recommendations to registered health professionals who provide advice and abortion care in Australia and Aotearoa New Zealand. RANZCOG supports equitable access to sexual

Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion at less than 12 weeks of gestation www.ajog.orgVerify you are human by completing the action below.www.ajog.org needs to review the security of your connection before proceeding.Ray ID: 8b419fa70b8f93f9Performance & security by Cloudflare

Mycophenolic acid and pregnancy: genotoxicity, malformations, spontaneous abortions Prescrire IN ENGLISH - Spotlight ''Mycophenolic acid and pregnancy: genotoxicity, malformations, spontaneous abortions'', 1 September 2022 {1}##LOC[OK]## {1} ##LOC[OK]## ##LOC[Cancel]## {1}##LOC[OK]####LOC[Cancel]## Register online| Log in| My Prescrire Issue contents * Current issue * Last 12 issues * All * Subscribe now * Solidarity Subscription Rate * Subscribers: register online * Prescrire's other products * Free Special Edition * Sign up to receive the newsletter english.prescrire.org > Spotlight > 100 most recent > Mycophenolic acid and pregnancy: genotoxicity, malformations, spontaneous abortions SpotlightEvery month, the subjects in Prescrire’s Spotlight. 100 most recent: 1|10|20|30|40|50